Literature DB >> 3297206

Analysis with antiidiotype antibody of a patient with chronic lymphocytic leukemia and a large cell lymphoma (Richter's syndrome).

L F Bertoli, H Kubagawa, G V Borzillo, M Mayumi, J T Prchal, J F Kearney, J R Durant, M D Cooper.   

Abstract

A murine monoclonal antibody made against an idiotypic determinant (Id) of surface IgM/IgD lambda molecules on chronic lymphocytic leukemia (CLL) cells of a 71-year-old woman was used for clonal analysis by two-color immunofluorescence. The anti-Id antibody identified IgM+/IgD+/lambda+ B cells as the predominant cell type of her CLL clone. In addition, substantial proportions of the IgG and IgA B cells and most of the IgM plasma cells in her bone marrow and blood were Id+. Six years after diagnosis, the patient died of respiratory failure due to infiltration of lungs by malignant cells. Autopsy revealed a dramatic change in the tumor cell morphology. The lungs, hilar nodes, and liver were infiltrated by a diffuse large cell lymphoma admixed with the leukemic cells. By immunohistologic staining these anaplastic lymphoma cells were IgM+/IgD-/lambda+ B cells expressing the same Id noted earlier on the CLL cells. The immunoglobulin gene rearrangement pattern on Southern blot analysis was also the same in leukemic blood cells and in the tissues involved by the lymphoma. Thus, the combination of antiidiotype and immunoglobulin gene analyses in this patient with Richter's syndrome revealed that a CLL clone, seemingly "frozen" in differentiation, was actually undergoing isotype switching, differentiation into plasma cells, and evolution into a rapidly growing and fetal lymphoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297206

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

Review 1.  The long elusive IgM Fc receptor, FcμR.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; Dewitt Jones; Naonori Nishida; Toshio Miyawaki; Luigi F Bertoli; Sheila K Sanders; Kazuhito Honjo
Journal:  J Clin Immunol       Date:  2014-05-03       Impact factor: 8.317

2.  Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia.

Authors:  Fu Jun Li; Yoshiki Kubagawa; Matthew K McCollum; Landon Wilson; Tomoko Motohashi; Luigi F Bertoli; James C Barton; Stephen Barnes; Randall S Davis; Hiromi Kubagawa
Journal:  Blood       Date:  2011-09-09       Impact factor: 22.113

3.  Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells.

Authors:  Andrea Cerutti; Hong Zan; Edmund C Kim; Shefali Shah; Elaine J Schattner; András Schaffer; Paolo Casali
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

4.  Centroblastic lymphoma of the thyroid supervening long-lasting chronic lymphocytic leukemia (B-CLL) demonstration of biclonality by immunohistochemical and gene rearrangement analysis.

Authors:  L Trümper; D U Matthaei-Maurer; W Knauf; P Möller
Journal:  Klin Wochenschr       Date:  1988-08-15

5.  A human lymphoma cell line with multiple immunoglobulin rearrangements.

Authors:  H Chang; H A Messner; X H Wang; C Yee; L Addy; J Meharchand; M D Minden
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.